Press "Enter" to skip to content

Combo Therapy More Than Doubled PFS in Platinum-Sensitive Recurrent Ovarian Cancer – Cancer Network

admin 0

Combo Therapy More Than Doubled PFS in Platinum-Sensitive Recurrent Ovarian Cancer  Cancer Network

The combination of the PARP inhibitor niraparib plus bevacizumab significantly improved progression-free survival in women with platinum-sensitive recurrent …

“ovarian cancer” – Google News

(Visited 5 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *